# Healthcare Realty Trust Inc (HR) Informational only - not investment advice. CIK: 0001360604 SIC: 6798 Real Estate Investment Trusts SIC breadcrumb: [Finance, Insurance, And Real Estate](/division/H/) > [Holding And Other Investment Offices](/major-group/67/) > [SIC 6798 Real Estate Investment Trusts](/industry/6798/) Latest 10-K filed: 2026-02-13 SEC page: https://www.sec.gov/edgar/browse/?CIK=1360604 Filing source: https://www.sec.gov/Archives/edgar/data/1360604/000136060426000018/hr-20251231.htm ## At a glance FY2025 · period end 2025-12-31 · filed 2026-02-13 · accession 0001360604-26-000018 · source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001360604.json | Metric | Value | FY | Provenance | | --- | ---: | ---: | --- | | Revenue | 1,180,546,000 USD | 2025 | verified | | Net income | -246,071,000 USD | 2025 | verified | | Assets | 9,210,861,000 USD | 2025 | verified | | Free cash flow | 126,942,000 USD | 2025 | computed | | Net margin | -20.84% | 2025 | computed | | Revenue YoY | -6.92% | 2025 | computed | | ROE | -5.33% | 2025 | computed | Computed values are grepcent-computed from the verified facts above and may differ from ratios the company itself reports. Free cash flow = operating cash flow − capital expenditures. Net margin = net income ÷ revenue. Revenue YoY = FY2025 revenue ÷ FY2024 revenue − 1 (consecutive fiscal years only). ROE = net income ÷ period-end stockholders' equity. No market price, no rating, no forecast on this site. Not investment advice. ### Peer percentile fingerprint | Ratio | HR | Peer median | Percentile | N | | --- | ---: | ---: | ---: | ---: | | Net margin | -20.8% | 16.8% | 7 | 149 | | Revenue growth | -6.9% | 3.7% | 15 | 149 | | FCF margin | 10.8% | 21.8% | 29 | 70 | | ROE | -5.3% | 5.7% | 13 | 151 | | ROA | -2.7% | 1.5% | 8 | 155 | | Liabilities / equity | 0.98 | 1.48 | 32 | 151 | Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC industry 6798 Real Estate Investment Trusts, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking. ## Selected Fundamentals | Metric | Value | Unit | FY | Filed | | --- | ---: | --- | ---: | --- | | Revenue | 1180546000 | USD | 2025 | 2026-02-13 | | Net income | -246071000 | USD | 2025 | 2026-02-13 | | Assets | 9210861000 | USD | 2025 | 2026-02-13 | ## Financials Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-02-13. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001360604.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts. | Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | 460,928,000 | 613,990,000 | 696,426,000 | 692,040,000 | 499,629,000 | 534,817,000 | 932,637,000 | 1,343,769,000 | 1,268,316,000 | 1,180,546,000 | | Net income | 45,912,000 | 63,916,000 | 213,463,000 | 30,154,000 | 72,195,000 | 66,659,000 | 40,897,000 | -278,261,000 | -654,485,000 | -246,071,000 | | Diluted EPS | 0.33 | 0.34 | 1.02 | 0.14 | 0.52 | 0.45 | 0.15 | -0.74 | -1.81 | -0.71 | | Operating cash flow | 203,695,000 | 307,543,000 | 337,396,000 | 340,394,000 | 470,089,000 | 232,629,000 | 272,747,000 | 499,820,000 | 501,617,000 | 457,095,000 | | Capital expenditures | | | | | 93,963,000 | 100,689,000 | 163,544,000 | 231,026,000 | 248,981,000 | 330,153,000 | | Dividends paid | 159,174,000 | 207,087,000 | 252,651,000 | 256,117,000 | 162,557,000 | 175,456,000 | 283,713,000 | 472,242,000 | 457,853,000 | 386,919,000 | | Share buybacks | 2,642,000 | 3,413,000 | 70,319,000 | 12,178,000 | 1,436,000 | 3,803,000 | 3,192,000 | 2,298,000 | 8,881,000 | 4,007,000 | | Assets | 3,747,844,000 | 6,449,582,000 | 6,188,476,000 | 6,638,749,000 | 6,790,692,000 | 4,258,919,000 | 13,849,631,000 | 12,637,131,000 | 10,650,923,000 | 9,210,861,000 | | Liabilities | 1,962,774,000 | 3,079,397,000 | 2,847,018,000 | 3,208,105,000 | 3,555,773,000 | 2,073,803,000 | 6,167,799,000 | 5,714,349,000 | 5,345,049,000 | 4,534,236,000 | | Stockholders' equity | 1,687,274,000 | 3,278,782,000 | 3,256,024,000 | 3,358,009,000 | 3,174,239,000 | 2,185,116,000 | 7,571,076,000 | 6,822,662,000 | 5,234,861,000 | 4,616,893,000 | | Cash and cash equivalents | 11,231,000 | 100,356,000 | 126,221,000 | 32,713,000 | 115,407,000 | 13,175,000 | 60,961,000 | 25,699,000 | 68,916,000 | 26,172,000 | | Free cash flow | | | | | 376,126,000 | 131,940,000 | 109,203,000 | 268,794,000 | 252,636,000 | 126,942,000 | ### Ratios ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported. | Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Net margin | 9.96% | 10.41% | 30.65% | 4.36% | 14.45% | 12.46% | 4.39% | -20.71% | -51.60% | -20.84% | | Return on equity | 2.72% | 1.95% | 6.56% | 0.90% | 2.27% | 3.05% | 0.54% | -4.08% | -12.50% | -5.33% | | Return on assets | 1.23% | 0.99% | 3.45% | 0.45% | 1.06% | 1.57% | 0.30% | -2.20% | -6.14% | -2.67% | | Liabilities / equity | 1.16 | 0.94 | 0.87 | 0.96 | 1.12 | 0.95 | 0.81 | 0.84 | 1.02 | 0.98 | ## As-reported value updates 13 tracked differences above grepcent's stated thresholds were found between the earliest XBRL-filed value and the value currently on file for the same fiscal period. Ledger: /company/HR/revisions/ ## Quarterly Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-07-30. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001360604.json. Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived. | Quarter | End date | Revenue | Net income | Diluted EPS | Method | | --- | --- | ---: | ---: | ---: | --- | | 2022-Q3 | 2022-09-30 | | | 0.08 | reported discrete quarter | | 2023-Q1 | 2023-03-31 | | | -0.23 | reported discrete quarter | | 2023-Q2 | 2023-06-30 | | | -0.22 | reported discrete quarter | | 2023-Q3 | 2023-09-30 | 342,260,000 | -67,844,000 | -0.18 | reported discrete quarter | | 2023-Q4 | 2023-12-31 | 330,441,000 | -40,533,000 | | derived Q4 = FY annual - nine-month YTD | | 2024-Q1 | 2024-03-31 | 326,805,000 | -310,836,000 | -0.82 | reported discrete quarter | | 2024-Q2 | 2024-06-30 | 316,322,000 | -143,780,000 | -0.39 | reported discrete quarter | | 2024-Q3 | 2024-09-30 | 315,423,000 | -93,023,000 | -0.26 | reported discrete quarter | | 2024-Q4 | 2024-12-31 | 309,766,000 | -106,846,000 | | derived Q4 = FY annual - nine-month YTD | | 2025-Q1 | 2025-03-31 | 298,977,000 | -44,873,000 | -0.13 | reported discrete quarter | | 2025-Q2 | 2025-06-30 | 297,502,000 | -157,851,000 | -0.45 | reported discrete quarter | | 2025-Q3 | 2025-09-30 | 297,765,000 | -57,738,000 | -0.17 | reported discrete quarter | | 2025-Q4 | 2025-12-31 | 286,303,000 | 14,391,000 | | derived Q4 = FY annual - nine-month YTD | | 2026-Q1 | 2026-03-31 | 278,990,000 | -56,000 | 0.00 | reported discrete quarter | | 2026-Q2 | 2026-06-30 | 281,849,000 | -43,514,000 | -0.13 | reported discrete quarter | ## Filed narrative (10-K & 10-Q) ## Business Verbatim Item 1 Business section from HR's latest 10-K: [/company/HR/business/](/company/HR/business/). ## Risk Factors Verbatim Item 1A Risk Factors from HR's latest 10-K: [/company/HR/risk-factors/](/company/HR/risk-factors/). ## Latest quarter (10-Q) Latest 10-Q source: https://www.sec.gov/Archives/edgar/data/1360604/000136060426000064/hr-20260630.htm Extracted structurally from real Item 2 body heading to real Item 3/4 boundary. Published MD&A gate trimmed front/tail over-capture. Confidence: high Filing date: 2026-07-30 Report date: 2026-06-30 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations The following discussion and analysis should be read together with the Condensed Consolidated Financial Statements and related Notes thereto included in Item 1 of this Quarterly Report on Form 10-Q. Other important factors are identified in our Annual Report on Form 10-K for the year ended December 31, 2025, including factors identified under the headings “Business,” “Risk Factors,” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations." Unless stated otherwise or the context otherwise requires, references to the "Company," "we," "us," and "our" are to Healthcare Realty Trust and its consolidated subsidiaries, including the OP. Disclosure Regarding Forward-Looking Statements This report contains disclosures that are “forward-looking statements.” Forward-looking statements include all statements that do not relate solely to historical or current facts and can often be identified by the use of words such as “may,” “will,” “expect,” “believe,” “anticipate,” “target,” “intend,” “plan,” “estimate,” “project,” “continue,” “should,” “could” and other comparable terms. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of risks and uncertainties that could materially affect the Company’s current plans and expectations and future financial condition and results. Such risks and uncertainties as more fully discussed in Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 and in other reports filed by the Company with the SEC from time to time include, among other things, the following: Risks relating to our business and operations •The Company's expected results may not be achieved; •The Company’s revenues depend on the ability of its tenants under its leases to generate sufficient income from their operations to make rental payments to the Company; •The Company's results of operations have been and will continue to be impacted negatively by the Prospect Medical bankruptcy; •Owning real estate and indirect interests in real estate is subject to inherent risks; •The Company may incur impairment charges on its real estate properties or other assets; •The Company has properties subject to purchase options that expose it to reinvestment risk and reduction in expected investment returns; •If the Company is unable to promptly re-let its properties, if the rates upon such re-letting are significantly lower than the previous rates or if the Company is required to undertake significant expenditures or make significant leasing concessions to attract new tenants, then the Company’s business, consolidated financial condition and results of operations would be adversely affected; •Certain of the Company’s properties are special purpose healthcare facilities and may not be easily adaptable to other uses; •The Company has, and in the future may have more exposure to fixed rent escalators, which could lag behind inflation and the growth in operating expenses such as real estate taxes, utilities, insurance, and maintenance expense; •The Company’s real estate investments are illiquid and the Company may not be able to sell properties strategically targeted for disposition; •The Company is subject to risks associated with the development and redevelopment of properties; •The Company may make material acquisitions and undertake developments and redevelopments that may involve the expenditure of significant funds and may not perform in accordance with management’s expectations; •The Company is exposed to risks associated with geographic concentration; •Many of the Company’s leases are dependent on the viability of associated health systems. Revenue concentrations relating to these leases expose the Company to risks related to the financial condition of the associated health systems; 27 Table of Contents •Many of the Company’s properties are held under ground leases. These ground leases contain provisions that may limit the Company’s ability to lease, sell, or finance these properties; •The Company may experience uninsured or underinsured losses; •Damage from catastrophic weather and other natural events, whether caused by climate change or otherwise, could result in losses to the Company; •The Company faces risks associated with security breaches through cyber attacks, cyber intrusions, or otherwise, as well as other significant disruptions of its information technology networks and related systems; •The Company has structured and may in the future structure acquisitions of property in exchange for limited partnership units of the OP on terms that could limit its liquidity or flexibility; •Healthcare Realty Trust is a holding company with no direct operations and, as such, it relies on funds received from the OP to pay liabilities, and the interests of its stockholders will be structurally subordinated to all liabilities and obligations of the OP and its subsidiaries; •The Company cannot assure you that it will be able to continue paying dividends at or above the rates previously paid; •Pandemics, and measures intended to prevent their spread or mitigate their severity could have a material adverse effect on the Company's business, results of operations, cash flows and financial condition; and •The Company's success depends, in part, on its ability to attract and retain talented employees. The loss of any one of the Company's key personnel or the inability to maintain appropriate staffing could adversely impact the Company's business. Risks relating to our capital structure and financings •The Company has incurred significant debt obligations and may incur additional debt and increase leverage in the future; •Covenants in the Company’s debt instruments limit its operational flexibility, and a breach of these covenants could materially affect the Company’s consolidated financial condition and results of operations; •If lenders under the Revolving Facility fail to meet their funding commitments, the Company’s operations and consolidated financial position would be negatively impacted; •The unavailability of equity and debt capital, volatility in the credit markets, increases in interest rates, or changes in the Company’s debt ratings could have an adverse effect on the Company’s ability to meet its debt payments, make dividend payments to stockholders or engage in acquisition and development activity; •Increases in interest rates could have a material adverse effect on the Company's cost of capital; •The Company's swap agreements may not effectively reduce its exposure to changes in interest rates; •The Company has entered into joint venture agreements that limit its flexibility with respect to jointly owned properties and may enter into additional such agreements in the future; •The U.S. federal income tax treatment of the cash that the Company might receive from cash settlement of a forward equity agreement is unclear and could jeopardize the Company's ability to meet the REIT qualification requirements; and •In case of our bankruptcy or insolvency, any forward equity agreements will automatically terminate, and the Company would not receive the expected proceeds from any forward sale of shares of its common stock. Risks relating to government regulations •The Company's property taxes could increase due to reassessment or property tax rate changes; •Trends in the healthcare service industry, including the impact of the One Big Beautiful Bill Act passed during 2025 that is subject of ongoing analysis, may negatively affect the demand for the Company’s properties, lease revenues and the values of its investments; •The costs of complying with governmental laws and regulations may adversely affect the Company's results of operations; •Qualifying as a REIT involves highly technical and complex provisions of the Internal Revenue Code; 28 Table of Contents •If the Company fails to remain qualified as a REIT, the Company will be subject to significant adverse consequences, including adversely affecting the value of its common stock; •The Company’s articles of incorporation, as well as provisions of the MGCL, contain limits and restrictions on transferability of the Company’s common stock which may have adverse effects on the value of the Company’s common stock; •Complying with the REIT requirements may cause the Company to forego otherwise attractive opportunities; •The prohibited transactions tax may limit the Company's ability to sell properties; •New legislation or administrative or judicial action, in each instance potentially with retroactive effect, could make it more difficult or impossible for the Company to qualify as a REIT; •New and increased transfer tax rates may reduce the value of the Company’s properties. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Stockholders and investors are cautioned not to unduly rely on such forward-looking statements, including, without limitation, estimates and projections regarding the performance of development projects the Company is pursuing. Liquidity and Capital Resources Sources and Uses of Cash The Company's revenues are derived from its real estate property portfolio based on contractual arrangements with its tenants. These sources of revenue represent the Company's primary source of liquidity to fund its dividends and its operating expenses, including interest incurred on debt, principal payments on debt, general and administrative costs, capital expenditures and other expenses incurred in connection with managing its existing portfolio and investing in additional properties. To the extent additional investments are not funded by these sources, the Company expects to fund its investment activity generally through equity or debt issuances either in the public or private markets, asset sales and joint venture contributions or through proceeds from the Revolving Facility and Commercial Paper Program. As of June 30, 2026, the Company had $1.6 billion available to be drawn on the Delayed Draw Term Loan and Revolving Facility, net of Commercial Paper Program borrowings, and available cash. The Company expects to continue to meet its liquidity needs, including capital for additional investments, tenant improvement allowances, operating and finance lease payments, paying dividends, share repurchases, and funding debt service, through cash on hand, cash flows from operations and the cash flow sources addressed above. Management believes that the Company's liquidity and sources of capital are adequate to satisfy our short and long-term cash requirements. The Company cannot, however, be certain that these sources of funds will be available at a time and upon terms acceptable to the Company in sufficient amounts to meet its liquidity needs. See Notes 4 and 7 to the Condensed Consolidated Financial Statements in this report for more information about capital markets and financing activities. Operating Activities Cash flows provided by operating activities decreased from $211.0 million for the six months ended June 30, 2025 to $195.1 million for the six months ended June 30, 2026. Items impacting cash flows from operations include, but are not limited to, cash generated from property operations, interest payments and the timing of the payment of invoices and other expenses. The Company may, from time to time, sell properties and redeploy cash from property sales into new investments or to repay indebtedness. The income from the new investments or reduction in interest expense could be less than the income from properties sold which would adversely affect the Company's results of operations and cash flows. Investing Activities Cash flows used in inve [Excerpt truncated for page length; source filing is linked above.] ## Latest 10-K MD&A (excerpt) Latest 10-K Item 7 source: https://www.sec.gov/Archives/edgar/data/1360604/000136060426000018/hr-20251231.htm Complete FY 2025 MD&A: /company/HR/mda/fy2025/ Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Confidence: high Filing date: 2026-02-13 Report date: 2025-12-31 Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations Disclosure Regarding Forward-Looking Statements This report and other materials the Company has filed or may file with the SEC, as well as information included in oral statements or other written statements made, or to be made, by senior management of the Company, contain, or will contain, disclosures that are “forward-looking statements.” Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as “may,” “will,” “expect,” “believe,” “anticipate,” “target,” “intend,” “plan,” “estimate,” “project,” “continue,” “should,” “could” and other comparable terms. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of risks and uncertainties that could materially affect the Company’s current plans and expectations and future financial condition and results. Such risks and uncertainties as more fully discussed in Item 1A “Risk Factors” of this report and in other reports filed by the Company with the SEC from time to time include, among other things, the following: Risks relating to our business and operations •The Company's expected results may not be achieved; •The Company’s revenues depend on the ability of its tenants under its leases to generate sufficient income from their operations to make rental payments to the Company; •The Company's results of operations have been and will continue to be impacted negatively by the Prospect Medical bankruptcy; •Owning real estate and indirect interests in real estate is subject to inherent risks; •The Company may incur impairment charges on its real estate properties or other assets; •The Company has properties subject to purchase options that expose it to reinvestment risk and reduction in expected investment returns; •If the Company is unable to promptly re-let its properties, if the rates upon such re-letting are significantly lower than the previous rates or if the Company is required to undertake significant expenditures or make significant leasing concessions to attract new tenants, then the Company’s business, consolidated financial condition and results of operations would be adversely affected; •Certain of the Company’s properties are special purpose healthcare facilities and may not be easily adaptable to other uses; •The Company has, and in the future may have more exposure to fixed rent escalators, which could lag behind inflation and the growth in operating expenses such as real estate taxes, utilities, insurance, and maintenance expense; •The Company’s real estate investments are illiquid and the Company may not be able to sell properties strategically targeted for disposition; •The Company is subject to risks associated with the development and redevelopment of properties; •The Company may make material acquisitions and undertake developments and redevelopments that may involve the expenditure of significant funds and may not perform in accordance with management’s expectations; •The Company is exposed to risks associated with geographic concentration; •Many of the Company’s leases are dependent on the viability of associated health systems. Revenue concentrations relating to these leases expose the Company to risks related to the financial condition of the associated health systems; •Many of the Company’s properties are held under ground leases. These ground leases contain provisions that may limit the Company’s ability to lease, sell, or finance these properties; •The Company may experience uninsured or underinsured losses; •Damage from catastrophic weather and other natural events, whether caused by climate change or otherwise, could result in losses to the Company; 25 •The Company faces risks associated with security breaches through cyber attacks, cyber intrusions, or otherwise, as well as other significant disruptions of its information technology networks and related systems; •The Company has structured and may in the future structure acquisitions of property in exchange for limited partnership units of the OP on terms that could limit its liquidity or flexibility; •Healthcare Realty Trust is a holding company with no direct operations and, as such, it relies on funds received from the OP to pay liabilities, and the interests of its stockholders will be structurally subordinated to all liabilities and obligations of the OP and its subsidiaries •The Company cannot assure you that it will be able to continue paying dividends at or above the rates previously paid; •Pandemics and measures intended to prevent their spread or mitigate their severity could have a material adverse effect on the Company's business, results of operations, cash flows and financial condition; and •The Company's success depends, in part, on its ability to attract and retain talented employees. The loss of any one of the Company's key personnel or the inability to maintain appropriate staffing could adversely impact the Company's business. Risks relating to our capital structure and financings •The Company has incurred significant debt obligations and may incur additional debt and increase leverage in the future; •Covenants in the Company’s debt instruments limit its operational flexibility, and a breach of these covenants could materially affect the Company’s consolidated financial condition and results of operations; •If lenders under the Unsecured Credit Facility fail to meet their funding commitments, the Company’s operations and consolidated financial position would be negatively impacted; •The unavailability of equity and debt capital, volatility in the credit markets, increases in interest rates, or changes in the Company’s debt ratings could have an adverse effect on the Company’s ability to meet its debt payments, make dividend payments to stockholders or engage in acquisition and development activity; •Increases in interest rates could have a material adverse effect on the Company's cost of capital; •The Company's swap agreements may not effectively reduce its exposure to changes in interest rates; •The Company has entered into joint venture agreements that limit its flexibility with respect to jointly owned properties and expects to enter into additional such agreements in the future; •The U.S. federal income tax treatment of the cash that the Company might receive from cash settlement of a forward equity agreement is unclear and could jeopardize the Company's ability to meet the REIT qualification requirements; and •In the event of our bankruptcy or insolvency, any forward equity agreements will automatically terminate, and the Company would not receive the expected proceeds from any forward sale of shares of its common stock. Risks relating to government regulations •The Company's property taxes could increase due to reassessment or property tax rate changes; •Trends in the healthcare service industry, including the impact of the One Big Beautiful Bill Act passed during 2025 that is subject of ongoing analysis, may negatively affect the demand for the Company’s properties, lease revenues and the values of its investments; •The costs of complying with governmental laws and regulations may adversely affect the Company's results of operations; •Qualifying as a REIT involves highly technical and complex provisions of the Internal Revenue Code; •If the Company fails to remain qualified as a REIT, the Company will be subject to significant adverse consequences, including adversely affecting the value of its common stock; •The Company’s articles of incorporation, as well as provisions of the MGCL, contain limits and restrictions on transferability of the Company’s common stock which may have adverse effects on the value of the Company’s common stock; 26 •Complying with the REIT requirements may cause the Company to forego otherwise attractive opportunities; •The prohibited transactions tax may limit the Company's ability to sell properties; •New legislation or administrative or judicial action, in each instance potentially with retroactive effect, could make it more difficult or impossible for the Company to qualify as a REIT; and •New and increased transfer tax rates may reduce the value of the Company’s properties. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Stockholders and investors are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in the Company’s filings and reports, including, without limitation, estimates and projections regarding the performance of development projects the Company is pursuing. Overview The Company owns and operates properties that facilitate the delivery of healthcare services in primarily outpatient settings. To execute its strategy, the Company engages in a broad spectrum of integrated services including leasing, management, acquisition, financing, development and redevelopment of such properties. The Company seeks to generate stable, growing income and lower the long-term risk profile of its portfolio of properties by focusing on facilities primarily located on or near the campuses of acute care hospitals associated with leading health systems. The Company seeks to reduce financial and operational risk by owning properties in high-growth markets with a broad tenant mix that includes over 30 physician specialties, as well as surgery, imaging, cancer, and diagnostic centers. This section is organized into the following sections: •Liquidity and Capital Resources; •Trends and Matters Impacting Operating Results; •Results of Operations; •Non-GAAP Financial Measures and Key Performance Indicators; and •Application of Critical Accounting Policies to Accounting Estimates. Liquidity and Capital Resources The Company monitors its liquidity and capital resources and considers several indicators in its assessment of capital markets for financing acquisitions and other operating activities. The Company considers, among other factors, its leverage ratios and lending covenants, dividend payout percentages, interest rates, underlying treasury rates, debt market spreads and cost of equity capital to compare its operations to its peers and to help identify areas in which the Company may need to focus its attention. Sources and Uses of Cash The Company's revenues are derived from its real estate property portfolio based on contractual arrangements with its tenants. These sources of revenue represent the Company's primary source of liquidity to fund its dividends and its operating expenses, including interest incurred on debt, principal payments on debt, general and administrative costs, capital expenditures and other expenses incurred in connection with managing its existing portfolio and investing in additional properties. To the extent additional investments are not funded by these sources, the Company will fund its investment activity generally through equity or debt issuances either in the public or private markets, asset sales and joint venture contributions or through proceeds from the Unsecured Credit Facility. The Company expects to continue to meet its liquidity needs, including capital for additional investments, tenant improvement allowances, operating and finance lease payments, paying dividends, and funding debt service, through cash on hand, cash flows from operations and the cash flow sources addressed above. See Note 3 to the Consolidated Financial Statements for additional discussion of operating and financing lease payment obligations. See "Trends and Matters Impacting Operating Results" for additional information regarding the Company's sources and uses of cash. 27 The Company also had unencumbered real estate as [Excerpt truncated for page length; the complete text is on the linked full-MD&A page.] Read the full FY 2025 MD&A: /company/HR/mda/fy2025/ All MD&A years: /company/HR/mda/ ## MD&A history Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page. - [FY 2024 MD&A](/company/HR/mda/fy2024/): filed 2025-02-19; accession 0001360604-25-000032 (https://www.sec.gov/Archives/edgar/data/1360604/000136060425000032/hr-20241231.htm) - [FY 2023 MD&A](/company/HR/mda/fy2023/): filed 2024-02-16; accession 0001360604-24-000026 (https://www.sec.gov/Archives/edgar/data/1360604/000136060424000026/hr-20231231.htm) - [FY 2022 MD&A](/company/HR/mda/fy2022/): filed 2023-03-01; accession 0001360604-23-000019 (https://www.sec.gov/Archives/edgar/data/1360604/000136060423000019/hr-20221231.htm) - [FY 2021 MD&A](/company/HR/mda/fy2021/): filed 2022-03-01; accession 0001360604-22-000014 (https://www.sec.gov/Archives/edgar/data/1360604/000136060422000014/hta-20211231.htm) ## Macro cross-references Indicators mapped to this company's SIC classification (industry 6798 Real Estate Investment Trusts) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim. - [DGS10](/indicator/DGS10/): Market Yield on U.S. Treasury Securities at 10-Year Constant Maturity - [HOUST](/indicator/HOUST/): New Privately-Owned Housing Units Started: Total Units - [PERMIT](/indicator/PERMIT/): New Privately-Owned Housing Units Authorized in Permit-Issuing Places: Total Units - [FEDFUNDS](/indicator/FEDFUNDS/): Federal Funds Effective Rate Macro-to-micro threads including this sector: [Interest rates & the Fed](/thread/interest-rates-fed/), [Money & trade](/thread/money-trade/), [Government finances](/thread/government-finances/), [Sector employment](/thread/sector-employment/). All macro indicators: /indicators/ ## For LLMs & downloads Markdown twin: /company/HR.md · JSON record: /company/HR.json · verified financials: /company/HR/financials.json / /company/HR/financials.csv · machine TOC for the whole site: /llms.txt